Share This

濟民醫療:公司目前幹細胞藥物研發管線相關項目均處於臨床前階段 項目較為早期

2024-05-08T17:08

... 5月8日,濟民醫療發佈股票交易異常波動的公告,公司目前幹細胞藥物研發管線相關項目均處於臨床前階段,項目較為早期。創新藥研發周期長、環節多、風險高,從研制、臨床試驗、報批到投產容易受到技術、審批、政策等諸多因素影響,後續的研發推進存在諸多的不確定性。(財聯社)

...
 recommend this page to friend   Details 
 
 
 Related news
  Search   More 
 Latest News
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.